Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer

Currently there are no FDA approved targeted therapies for Triple Negative Breast Cancer (TNBC). Ongoing clinical trials for TNBC have focused primarily on targeting the epithelial cancer cells. However, targeted delivery of cytotoxic payloads to the non-transformed tumor associated-endothelium can...

Descripción completa

Detalles Bibliográficos
Autores principales: Upreti, Meenakshi, Jyoti, Amar, Johnson, Sara E., Swindell, Elden P., Napier, Dana, Sethi, Pallavi, Chan, Ryan, Feddock, Jonathan M., Weiss, Heidi L., O'Halloran, Thomas V., Mark Evers, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173078/
https://www.ncbi.nlm.nih.gov/pubmed/27223428
http://dx.doi.org/10.18632/oncotarget.9490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173078/
https://www.ncbi.nlm.nih.gov/pubmed/27223428
http://dx.doi.org/10.18632/oncotarget.9490

Ejemplares similares